Prospective Analysis of the Use of TEG in Stroke Patients "TEG"


Phase N/A Results N/A

Summary of Purpose

The overall purpose of this study is to evaluate how effective Thromboelastography (TEG) is on identifying ischemic and hemorrhagic stroke patients at increased risk for bleeding after receiving tissue plasminogen activator (tPA), as well as on differentiating between patients in whom optimal thrombolysis has been achieved, and those whom it has not.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 July 2015.

1 Nov 2009 4 Jul 2015 1 May 2014 1 Dec 2014 1 Jul 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Case Control
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


Not available